Protecting Your Heart During Anthracycline Chemotherapy
If you’re undergoing chemotherapy with anthracycline drugs (such as Adriamycin/doxorubicin, daunorubicin, epirubicin, or idarubicin), protecting your heart health is crucial. These medications, while effective against cancer, can potentially cause heart problems that might not show up until years later.
. Last modified on : Feb 18 2025Research Takeaway: I received heart-damaging treatment. How often do I need an echocardiogram?
Recent research underscores the importance of monitoring heart health before and after chemotherapy, especially for patients undergoing heart-damaging (cardiotoxic) treatments such as anthracyclines or trastuzumab. A 2025 study followed over 800 breast cancer survivors for an average of eight years. The researchers found that cardiac dysfunction increased over time, from 1.8% at two years after treatment to 15.3% at 15 years.
. First published on : Feb 03 2025Repurposed Drugs in Cancer Care
With widespread access to cancer research studies and anecdotal stories through internet searches and social media, people with cancer are becoming increasingly proactive in exploring all available treatment options. This trend has spurred grassroots adoption of complex supplement regimens and repurposed drug protocols. The fact that there is some evidence for various repurposed drugs to improve cancer outcomes makes it tempting for individuals to assume these drugs will help their cancer.
. First published on : Jan 28 2025Fenbendazole and Cancer: A Closer Look at Its Use and Risks
CancerChoices reviews and synthesizes the evidence behind complementary therapies including repurposed drugs. Given the significant interest in our review of Mebendazole and Fenbendazole, and our accompanying article on repurposed drugs, we’ve partnered with Mark Taylor of Patient Led Oncology to provide a deeper analysis of Fenbendazole.
. Last modified on : Feb 17 2025Meet the Practitioner: Dr. Linda E. Carlson, Psychosocial Oncology
Dr. Linda Carlson is a globally recognized leader in psychosocial and integrative oncology, specializing in developing and evaluating complementary therapies to improve the lives of people with cancer. These include mindfulness-based programs, yoga, acupuncture and creative therapies. Known for her research creativity and productivity, she blends cutting-edge research with clinical expertise to advance holistic cancer […]
. Last modified on : Jan 28 2025What Matters Now: Reflective Questions for Life After a Cancer Diagnosis
Exploring the question, “what matters now” may help us find what most needs healing in our lives. This exploration leads to deeper questions on how we wish to live after a life changing diagnosis.
. First published on : Dec 17 2024Nourishing Your Holidays: Cranberry, Orange, and Apple Relish
Cranberries pack antioxidants, vitamin C, and prebiotic fiber for immune and gut health. This recipe blends cranberries, apples, oranges, and Grade B maple syrup—bringing festive flavors to holiday meals without added sugars or preservatives.
. First published on : Nov 11 2024Meet the Practitioner: Taylor Scialo RD, MS, CSO, CDN, Oncology Registered Dietitian Nutritionist
Navigating nutrition during cancer treatment can be overwhelming. Taylor Scialo shares her expertise on the role of nutrition in cancer care, the differences between dietitians and nutritionists, and the complexities of conducting meaningful nutrition research.
. Last modified on : Jan 07 2025Anticancer Nourishment: Apple, Pear, and Blueberry Crisp
Try this delicious apple, pear, and blueberry crisp recipe from CancerChoices’ Senior Clinical Consultant, health-supportive chef, and culinary translator, Laura Pole, for a tasty way to enjoy apples this season.
. Last modified on : Oct 23 2024Meet the Practitioner: Dr. Jen Green, ND, FABNO, Naturopathic Oncologist
In this insightful podcast, Dr. Jen Green, a naturopathic doctor specializing in oncology, provides a wealth of information about integrative oncology and how it can complement conventional cancer care.
. Last modified on : Nov 07 2024